Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

idbio.eu

Stage

Acquired | Acquired

About ID bio

ID bio is a French company specialized in classical or biotechnological extraction and purification of botanical substances.

ID bio Headquarters Location

Ester Technopole, 6

Limoges, 87068,

France

+33-555-35-05-35

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

ID bio Patents

ID bio has filed 26 patents.

The 3 most popular patent topics include:

  • Vaccines
  • Animal viral diseases
  • Animal virology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/28/2014

9/6/2016

Clusters of differentiation, Immunology, Immune system, Cytokines

Grant

Application Date

4/28/2014

Grant Date

9/6/2016

Title

Related Topics

Clusters of differentiation, Immunology, Immune system, Cytokines

Status

Grant

Latest ID bio News

Novacap changes names to Seqens

Jan 7, 2019

Novacap changes names to Seqens Novacap and all its activities and subsidiaries (Novacarb, Novacyl, Novapex, Novacid, Novabay, Uetikon, H2B, ID Bio , PCAS, Chemoxy and PCI Synthesis) unify their names into a new one and become Seqens. Specialising in pharmaceutical synthesis and specialty ingredients for the healthcare, electronic, cosmetic, food and homecare markets, the group operates 24 manufacturing plants and three R&D centres in Europe, North America and Asia with 3,200 employees. Seqens refers naturally to the group core synthesis activities, mixed with that sequencing idea. “As Seqens, we intend to stand as a strong, global and integrated player in pharmaceutical synthesis and specialty ingredients. Our mission is to bring R&D and industrial performance to our clients’ projects. From now on, we want to better leverage on our strong expertise to develop and produce highly complex molecules with unique skills and the largest continuum of technologies available on the market. I am proud of what we have achieved so far, on behalf of Seqens’ 3,200 scientists, engineers, and experts working across a range of fields such as QHSE, industrial methods and processes, quality, sales and marketing, finance, innovation, legal and more,” says Pierre Luzeau, Seqens CEO. © 2019 - Premium Beauty News - www.premiumbeautynews.com latest news

  • Where is ID bio's headquarters?

    ID bio's headquarters is located at Ester Technopole, 6, Limoges.

  • What is ID bio's latest funding round?

    ID bio's latest funding round is Acquired.

  • Who are the investors of ID bio?

    Investors of ID bio include SEQENS.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.